Featured Press Releases

Innovent Announces Approval from China

Innovent Announces Approval from China's NMPA for Mazdutide, the First Dual GCG/GLP-1 Receptor Agonist, for Chronic Weight Management

S&E Bio Secures Korea’s First Approval for a Clinical Trial of Exosome-Based Therapy

S&E Bio Secures Korea’s First Approval for a Clinical Trial of Exosome-Based Therapy

  • 02 May 2025

S&E bio Co., Ltd., a biotechnology company specializing in exosomal microRNA-based therapies, has...

Harbour BioMed receives NMPA IND clearance for HBM9378/SKB378 in treating chronic obstructive pulmonary disease

Harbour BioMed receives NMPA IND clearance for HBM9378/SKB378 in treating chronic obstructive pulmonary disease

To expand biopharma services with its liquid biopsy capabilities, Precision for Medicine partners with SOPHiA GENETICS on the SOPHiA DDM™ platform

To expand biopharma services with its liquid biopsy capabilities, Precision for Medicine partners with SOPHiA GENETICS on the SOPHiA DDM™ platform

Cannabix Technologies and Omega Laboratories Announce a DOT-Like Breath-Based Drug Testing Panel for Recent-Use Detection

Cannabix Technologies and Omega Laboratories Announce a DOT-Like Breath-Based Drug Testing Panel for Recent-Use Detection

Aptar Pharma and Massachusetts General Hospital Collaborate on Platform to Establish a Predictive, Data-Driven Model for Advancing Nose-to-Brain Drug Delivery

Aptar Pharma and Massachusetts General Hospital Collaborate on Platform to Establish a Predictive, Data-Driven Model for Advancing Nose-to-Brain Drug Delivery

BD Strengthens Peripheral Vascular Innovation Leadership with Positive AGILITY Trial Results

BD Strengthens Peripheral Vascular Innovation Leadership with Positive AGILITY Trial Results

  • BD
  • 08 Oct 2026
The meeting will focus on Nordic Pharma, Inc.’s patient data and study results on LACRIFILL® Canalicular Gel, a novel ocular surface therapy

The meeting will focus on Nordic Pharma, Inc.’s patient data and study results on LACRIFILL® Canalicular Gel, a novel ocular surface therapy

  • Nordic Pharma, Inc.
  • 08 Oct 2026
Arkayli Biopharma Inc. Receives FDA Study May Proceed Response to IND and NIH SBIR Grant to Advance Clinical Development of ARK001 for a Rare Pediatric Disease

Arkayli Biopharma Inc. Receives FDA Study May Proceed Response to IND and NIH SBIR Grant to Advance Clinical Development of ARK001 for a Rare Pediatric Disease

  • Arkayli Biopharma Inc
  • 08 Oct 2026
Carterra Advances Drug Discovery Through New Lab-In-The-Loop Scientific Collaboration

Carterra Advances Drug Discovery Through New Lab-In-The-Loop Scientific Collaboration

  • Carterra
  • 07 Oct 2026
MedaSystems Announces Major Platform Update to Help Life Sciences Organizations Govern and Scale Expanded Access Programs

MedaSystems Announces Major Platform Update to Help Life Sciences Organizations Govern and Scale Expanded Access Programs

  • MedaSystems
  • 07 Oct 2026
Dr. Oregonin Completes U.S. FDA Registration for OLTIS DENTAL-X, Unveiling Oral Care Innovation Rooted in Trans-Pacific Alder Research

Dr. Oregonin Completes U.S. FDA Registration for OLTIS DENTAL-X, Unveiling Oral Care Innovation Rooted in Trans-Pacific Alder Research

  • Dr. Oregonin Inc
  • 06 Oct 2026

Most Popular
October   2026
M T W T F S S
      1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31  

User Area

Discover

Engage with Us

© Pharmaceutical Era — A product of HISSM. All Rights Reserved.